|
1
|
Donnez J and Dolmans MM: Fertility
preservation in women. Nat Rev Endocrinol. 9:735–749. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roberts J, Ronn R, Tallon N and Holzer H:
Fertility preservation in reproductive-age women facing gonadotoxic
treatments. Curr Oncol. 22:e294–e304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Loren AW, Mangu PB, Beck LN, Brennan L,
Magdalinski AJ, Partridge AH, Quinn G, Wallace WH and Oktay K;
American Society of Clinical Oncology, : Fertility preservation for
patients with cancer: American Society of Clinical Oncology
clinical practice guideline update. J Clin Oncol. 31:2500–2510.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muñoz M, Santaballa A, Seguí MA, Beato C,
de la Cruz S, Espinosa J, Fonseca PJ, Perez J, Quintanar T and
Blasco A: SEOM Clinical Guideline of fertility preservation and
reproduction in cancer patients (2016). Clin Transl Oncol.
18:1229–1236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Font-Gonzalez A, Mulder RL, Loeffen EA,
Byrne J, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM,
Hudson MM, Kenney LB, Levine JM, Tissing WJ, et al PanCareLIFE
Consortium, : Fertility preservation in children, adolescents, and
young adults with cancer: Quality of clinical practice guidelines
and variations in recommendations. Cancer. 122:2216–2223. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goldfarb SB, Kamer SA, Oppong BA, Eaton A,
Patil S, Junqueira MJ, Olcese C, Kelvin JF and Gemignani ML:
Fertility Preservation for the Young Breast Cancer Patient. Ann
Surg Oncol. 23:1530–1536. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Srikanthan A, Amir E and Warner E: Does a
dedicated program for young breast cancer patients affect the
likelihood of fertility preservation discussion and referral?
Breast. 27:22–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewin J, Ma JMZ, Mitchell L, Tam S, Puri
N, Stephens D, Srikanthan A, Bedard P, Razak A, Crump M, et al: The
positive effect of a dedicated adolescent and young adult fertility
program on the rates of documentation of therapy-associated
infertility risk and fertility preservation options. Support Care
Cancer. 25:1915–1922. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Atkins D, Best D, Briss PA, Eccles M,
Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry
D, et al GRADE Working Group, : Grading quality of evidence and
strength of recommendations. BMJ. 328:14902004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Metzger ML, Meacham LR, Patterson B,
Casillas JS, Constine LS, Hijiya N, Kenney LB, Leonard M, Lockart
BA, Likes W, et al: Female reproductive health after childhood,
adolescent, and young adult cancers: Guidelines for the assessment
and management of female reproductive complications. J Clin Oncol.
31:1239–1247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwase A, Nakamura T, Nakahara T, Goto M
and Kikkawa F: Anti-Müllerian hormone and assessment of ovarian
reserve after ovarian toxic treatment: A systematic narrative
review. Reprod Sci. 22:519–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rodriguez-Wallberg KA and Oktay K:
Fertility preservation during cancer treatment: Clinical
guidelines. Cancer Manag Res. 6:105–117. 2014.PubMed/NCBI
|
|
13
|
Ouhilal S, Lachgar H, Bissonnette F,
Buckett B, Kadoch I, St-Michel P and Mahutte N: Public funding of
IVF without age limits: A cautionary tale from Quebec. Fertil
Steril. 104:e2072015. View Article : Google Scholar
|
|
14
|
Chen H, Li J, Cui T and Hu L: Adjuvant
gonadotropin-releasing hormone analogues for the prevention of
chemotherapy induced premature ovarian failure in premenopausal
women. Cochrane Database Syst Rev (11): CD008018. 2011. View Article : Google Scholar
|
|
15
|
Clowse ME, Behera MA, Anders CK, Copland
S, Coffman CJ, Leppert PC and Bastian LA: Ovarian preservation by
GnRH agonists during chemotherapy: A meta-analysis. J Womens Health
(Larchmt). 18:311–319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SS, Lee JR, Jee BC, Suh CS, Kim SH,
Ting A and Petroff B: Use of hormonal protection for
chemotherapy-induced gonadotoxicity. Clin Obstet Gynecol.
53:740–752. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Del Mastro L, Ceppi M, Poggio F, Bighin C,
Peccatori F, Demeestere I, Levaggi A, Giraudi S, Lambertini M,
D'Alonzo A, et al: Gonadotropin-releasing hormone analogues for the
prevention of chemotherapy-induced premature ovarian failure in
cancer women: Systematic review and meta-analysis of randomized
trials. Cancer Treat Rev. 40:675–683. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Badawy A, Elnashar A, El-Ashry M and
Shahat M: Gonadotropin-releasing hormone agonists for prevention of
chemotherapy-induced ovarian damage: Prospective randomized study.
Fertil Steril. 91:694–697. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bedaiwy MA, Abou-Setta AM, Desai N, Hurd
W, Starks D, El-Nashar SA, Al-Inany HG and Falcone T:
Gonadotropin-releasing hormone analog cotreatment for preservation
of ovarian function during gonadotoxic chemotherapy: a systematic
review and meta-analysis. Fertil Steril. 95:906–914 e1-4. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang B, Shi W, Yang J, Liu H, Zhao H, Li X
and Jiao S: Concurrent treatment with gonadotropin-releasing
hormone agonists for chemotherapy-induced ovarian damage in
premenopausal women with breast cancer: A meta-analysis of
randomized controlled trials. Breast. 22:150–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sverrisdottir A, Nystedt M, Johansson H
and Fornander T: Adjuvant goserelin and ovarian preservation in
chemotherapy treated patients with early breast cancer: Results
from a randomized trial. Breast Cancer Res Treat. 117:561–567.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gerber B, von Minckwitz G, Stehle H,
Reimer T, Felberbaum R, Maass N, Fischer D, Sommer HL, Conrad B,
Ortmann O, et al German Breast Group Investigators, : Effect of
luteinizing hormone-releasing hormone agonist on ovarian function
after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO
study. J Clin Oncol. 29:2334–2341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Del Mastro L, Boni L, Michelotti A,
Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P,
Bighin C, et al: Effect of the gonadotropin-releasing hormone
analogue triptorelin on the occurrence of chemotherapy-induced
early menopause in premenopausal women with breast cancer: A
randomized trial. JAMA. 306:269–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Munster PN, Moore AP, Ismail-Khan R, Cox
CE, Lacevic M, Gross-King M, Xu P, Carter WB and Minton SE:
Randomized trial using gonadotropin-releasing hormone agonist
triptorelin for the preservation of ovarian function during
(neo)adjuvant chemotherapy for breast cancer. J Clin Oncol.
30:533–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elgindy EA, El-Haieg DO, Khorshid OM,
Ismail EI, Abdelgawad M, Sallam HN and Abou-Setta AM: Gonadatrophin
suppression to prevent chemotherapy-induced ovarian damage: A
randomized controlled trial. Obstet Gynecol. 121:78–86. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Demeestere I, Brice P, Peccatori FA,
Kentos A, Dupuis J, Zachee P, Casasnovas O, van den Neste E,
Dechene J, De Maertelaer V, et al: No evidence for the benefit of
gonadotropin-releasing hormone agonist in preserving ovarian
function and fertility in lymphoma survivors treated with
chemotherapy: Final long-term report of a prospective randomized
trial. J Clin Oncol. 34:2568–2574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wallace WH, Thomson AB, Saran F and Kelsey
TW: Predicting age of ovarian failure after radiation to a field
that includes the ovaries. Int J Radiat Oncol Biol Phys.
62:738–744. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moore HC, Unger JM, Phillips KA, Boyle F,
Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS,
et al POEMS/S0230 Investigators, : Goserelin for ovarian protection
during breast-cancer adjuvant chemotherapy. N Engl J Med.
372:923–932. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Terenziani M, Piva L, Meazza C, Gandola L,
Cefalo G and Merola M: Oophoropexy: a relevant role in preservation
of ovarian function after pelvic irradiation. Fertil Steril. 91:935
e15–6. 2009. View Article : Google Scholar
|
|
30
|
Williams RS, Littell RD and Mendenhall NP:
Laparoscopic oophoropexy and ovarian function in the treatment of
Hodgkin disease. Cancer. 86:2138–2142. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barahmeh S, Al Masri M, Badran O, Masarweh
M, El-Ghanem M, Jaradat I and Lataifeh I: Ovarian transposition
before pelvic irradiation: Indications and functional outcome. J
Obstet Gynaecol Res. 39:1533–1537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moawad NS, Santamaria E, Rhoton-Vlasak A
and Lightsey JL: Laparoscopic Ovarian Transposition Before Pelvic
Cancer Treatment: Ovarian Function and Fertility Preservation. J
Minim Invasive Gynecol. 24:28–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee SJ, Schover LR, Partridge AH, Patrizio
P, Wallace WH, Hagerty K, Beck LN, Brennan LV and Oktay K; American
Society of Clinical Oncology, : American Society of Clinical
Oncology recommendations on fertility preservation in cancer
patients. J Clin Oncol. 24:2917–2931. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Morice P, Thiam-Ba R, Castaigne D,
Haie-Meder C, Gerbaulet A, Pautier P, Duvillard P and Michel G:
Fertility results after ovarian transposition for pelvic
malignancies treated by external irradiation or brachytherapy. Hum
Reprod. 13:660–663. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zinger M, Liu JH, Husseinzadeh N and
Thomas MA: Successful surrogate pregnancy after ovarian
transposition, pelvic irradiation and hysterectomy. J Reprod Med.
49:573–574. 2004.PubMed/NCBI
|
|
36
|
Practice Committee of American Society for
Reproductive Medicine, . Ovarian tissue cryopreservation: A
committee opinion. Fertil Steril. 101:1237–1243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dolmans MM, Jadoul P, Gilliaux S, Amorim
CA, Luyckx V, Squifflet J, Donnez J and Van Langendonckt A: A
review of 15 years of ovarian tissue bank activities. J Assist
Reprod Genet. 30:305–314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bastings L, Beerendonk CC, Westphal JR,
Massuger LF, Kaal SE, van Leeuwen FE, Braat DD and Peek R:
Autotransplantation of cryopreserved ovarian tissue in cancer
survivors and the risk of reintroducing malignancy: A systematic
review. Hum Reprod Update. 19:483–506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luyckx V, Durant JF, Camboni A, Gilliaux
S, Amorim CA, Van Langendonckt A, Irenge LM, Gala JL, Donnez J and
Dolmans MM: Is transplantation of cryopreserved ovarian tissue from
patients with advanced-stage breast cancer safe? A pilot study. J
Assist Reprod Genet. 30:1289–1299. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sørensen SD, Greve T, Wielenga VT, Wallace
WH and Andersen CY: Safety considerations for transplanting
cryopreserved ovarian tissue to restore fertility in female
patients who have recovered from Ewing's sarcoma. Future Oncol.
10:277–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rodríguez-Iglesias B, Novella-Maestre E,
Herraiz S, Díaz-García C, Pellicer N and Pellicer A: New methods to
improve the safety assessment of cryopreserved ovarian tissue for
fertility preservation in breast cancer patients. Fertil Steril.
104:1493–1502. e2. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fernbach A, Lockart B, Armus CL, Bashore
LM, Levine J, Kroon L, Sylvain G and Rodgers C: Evidence-Based
Recommendations for Fertility Preservation Options for Inclusion in
Treatment Protocols for Pediatric and Adolescent Patients Diagnosed
With Cancer. J Pediatr Oncol Nurs. 31:211–222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ginsberg JP: Educational paper: The effect
of cancer therapy on fertility, the assessment of fertility and
fertility preservation options for pediatric patients. Eur J
Pediatr. 170:703–708. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Koch J and Ledger W: Ovarian stimulation
protocols for onco-fertility patients. J Assist Reprod Genet.
30:203–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Azim AA, Costantini-Ferrando M and Oktay
K: Safety of fertility preservation by ovarian stimulation with
letrozole and gonadotropins in patients with breast cancer: A
prospective controlled study. J Clin Oncol. 26:2630–2635. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cakmak H and Rosen MP: Random-start
ovarian stimulation in patients with cancer. Curr Opin Obstet
Gynecol. 27:215–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Canadian Fertility and Andrology Society,
. Human Assisted Reproduction 2013 Live Birth Rates for Canada.
http://www.cfas.ca/index.php?option=com_content&view=article&id=1205%3Alive-birth-rates-2012&catid=929%3Apress-releases&Itemid=130August
21–2014
|
|
48
|
Cil AP, Bang H and Oktay K: Age-specific
probability of live birth with oocyte cryopreservation: an
individual patient data meta-analysis. Fertil Steril. 100:492–499
e3. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Valentini A, Finch A, Lubinski J, Byrski
T, Ghadirian P, Kim-Sing C, Lynch HT, Ainsworth PJ, Neuhausen SL,
Greenblatt E, et al: Chemotherapy-induced amenorrhea in patients
with breast cancer with a BRCA1 or BRCA2 mutation. J Clin Oncol.
31:3914–3919. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
NCIC Clinical Trials Group, . NCIC
Clinical Trials. Breast Disease Site. 2015, https://www.ctg.queensu.ca/public/breast/breast-disease-site
|
|
51
|
Hill KA, Nadler T, Mandel R, Burlein-Hall
S, Librach C, Glass K and Warner E: Experience of young women
diagnosed with breast cancer who undergo fertility preservation
consultation. Clin Breast Cancer. 12:127–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Garvelink MM, Ter Kuile MM, Louwé LA,
Hilders CG and Stiggelbout AM: A Delphi consensus study among
patients and clinicians in the Netherlands on the procedure of
informing young breast cancer patients about Fertility
Preservation. Acta Oncol. 51:1062–1069. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Peate M, Meiser B, Cheah BC, Saunders C,
Butow P, Thewes B, Hart R, Phillips KA, Hickey M and Friedlander M:
Making hard choices easier: A prospective, multicentre study to
assess the efficacy of a fertility-related decision aid in young
women with early-stage breast cancer. Br J Cancer. 106:1053–1061.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Loren AW, Brazauskas R, Chow EJ, Gilleece
M, Halter J, Jacobsohn DA, Joshi S, Pidala J, Quinn GP, Wang Z, et
al: Physician perceptions and practice patterns regarding fertility
preservation in hematopoietic cell transplant recipients. Bone
Marrow Transplant. 48:1091–1097. 2013. View Article : Google Scholar : PubMed/NCBI
|
